All SEC Filings

Filing Type:

Year:

Date	Form	Description	Pages
06/21/22	8-K	Current report filing	2
06/03/22	8-K	Current report filing Documents EX-10.1 EX-10.2	18
05/24/22	8-K	Current report filing	2
05/16/22	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	33
04/27/22	QUALIF	Notice of Qualification [Regulation A]	1
04/26/22	CORRESP	A correspondence can be sent as a document with another submission type or can be sent as a separate submission.	1
04/19/22	1-A POS	Documents EX1A-4 SUBS AGMT EX1A-11 CONSENT EX1A-12 OPN CNSL	78
04/15/22	10-K	Annual report pursuant to Section 13 and 15(d) Documents EX-31.1 EX-31.2 EX-32.1	66
04/11/22	CORRESP	A correspondence can be sent as a document with another submission type or can be sent as a separate submission.	1
03/31/22	NT 10-K	Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT	2

Food and Drug Administration (FDA) Disclosure

Statements in this website have not been evaluated by the FDA and are not intended to diagnose, treat, or cure any disease. Always check with your physician before starting a new wellness or dietary program. Please view our full terms of use agreement for more information and the terms and conditions governing your use of this site. Cannabidiol (CBD) is a natural derivative of cannabis plants that promote and support nutrition, health and wellness, as well as anti-aging. Source: US Government Patent #6,630,507: "cannabinoids as antioxidants and neuroprotectants."

Marijuana Company of America, Inc. (MCOA) does not sell or distribute any products that are in violation of the united states controlled substances act (US CSA) in California. MCOA grows, produces, sells and distributes solutions for health, wellness, and anti-aging companies. MCOA solutions include cannabis- and/or CBD/CBN-based elements. Where allowed, MCOA may sell or distribute solutions containing THC. For more information, please contact us.